Trial
NCT02833701
Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI)
Condition
Glioblastoma
Intervention
Ascorbic Acid
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-24